Results 91 to 100 of about 4,527,439 (244)

Methotrexate-induced severe cutaneous adverse reactions:A literature-based case analysis

Pifu-xingbing zhenliaoxue zazhi
Objective To investigate the clinical characteristics, treatment strategies, and outcomes of Methotrexate（MTX）-induced severe cutaneous adverse reactions（SCARs）, thereby providing evidence-based guidance for medication safety.Methods We systematically ...
WANG Limei, LI Han, LUO Ping
doaj   +1 more source

Severe Cutaneous Adverse Reaction to Piperacillin-Tazobactam: A Case of Stevens-Johnson Syndrome. [PDF]

Cureus, 2023
Kumar H, Kumar A, Kumar S.
europepmc   +1 more source

Severe cicatricial alopecia as a rare cutaneous side effect due to erlotinib – case report

, 2016
Introduction . Epidermal growth factor receptor inhibitors (EGFRI) are commonly used in the treatment of solid tumors. Cutaneous side effects occur in 80% of patients and are the most frequent adverse events.
Aleksandra Batycka-Baran, Magdalena Żychowska, Wojciech Baran, Joanna Maj   +3 more
core   +1 more source

NMDAR‐antibody encephalitis: Seizure semiology and EEG findings

Epileptic Disorders, EarlyView.
Abstract Background N‐methyl‐D‐aspartate receptor antibody encephalitis (NMDAR‐Ab‐E) is an autoantibody‐mediated disorder, characterized by acute development of neuropsychiatric symptoms, seizures, movement disorders, and autonomic instability. Objectives To describe acute seizure semiology and electroencephalogram (EEG) findings in patients with a ...
Maria Emilia C. Andraus, Bernard Liem, Sidra Aurangzeb, Mkael Symmonds, Adam E. Handel, Sarosh R. Irani, Arjune Sen   +6 more
wiley   +1 more source

A case report of terbinafine-induced acute generalized exanthematous pustulosis in a striking photodistributed pattern

SAGE Open Medical Case Reports
Acute generalized exanthematous pustulosis is a rare severe cutaneous adverse reaction that classically presents in intertriginous or flexural areas and subsequently spreads diffusely across the trunk and extremities.
Charles D Lange, Laura Madden, Eva Rawlings Parker   +2 more
doaj   +1 more source

Long‐term efficacy of adjunctive cenobamate: Open‐label extension of a randomized, placebo‐controlled study in a multinational Asian population

Epilepsia, EarlyView.
Long‐term efficacy and safety of adjunctive cenobamate in a multinational Asian population. Open‐label extension (OLE) efficacy population included all patients who had taken ≥1 dose of study drug and had any seizure data during the OLE maintenance phase.
Sang Kun Lee, Peimin Yu, Eunyeong Choe, Louis Ferrari, Kyoung Heo, Seung Bong Hong, Zhen Hong, Koji Iida, Yong Heui Jeon, Jiwon Jung, Marc Kamin, Kensuke Kawai, Ji Hyun Kim, Myung Won Kim, Xiaorong Liu, Jungshin Park, William Rosenfeld, Takamichi Yamamoto, Dong Zhou, Suiqiang Zhu, Sunita N. Misra   +20 more
wiley   +1 more source

Lamotrigine-induced DRESS Syndrome in an Epileptic Patient: A Rare but Life-threatening Adverse Drug Reaction

Archives of Epilepsy
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare, potentially life-threatening hypersensitivity reaction characterized by fever, skin rash, eosinophilia, and multiple organ involvement.
Enes Durak, Aslı Aksoy Gündoğdu
doaj   +1 more source

Severe cutaneous adverse drug reactions of Chinese inpatients: a meta-analysis

, 2017
Background: The rate of severe cutaneous adverse drug reactions is low, and these reactions can result in death or disability. An evidence-based epidemiological study of severe cutaneous adverse drug reactions in China has not been reported.
Huang,Jinhua, Jing,Chen, Jinhua Huang, Xia Fang, Chen Jing, Deng,Qiancheng, Jianyun Lu, Zeng,Qinghai, Qiancheng Deng, Fang,Xia, Qinghai Zeng, Lu,Jianyun   +11 more
core   +1 more source

Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions [PDF]

, 2017
Diagnosis of severe cutaneous adverse drug reactions should involve immunohistopathological examination, which gives insight into the pathomechanisms of these disorders.
Mari Orime
core   +1 more source

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

Head &Neck, EarlyView.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell, E. C. Ward, L. R. Wishart, R. Perera, C. Barrett, K. A. Edmiston, E. Mitchell, A. Pigott, R. Pitt, K. Russell, B. A. Chan, R. Ladwa   +11 more
wiley   +1 more source